German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.
Science Exchange has raised $28 million in its third funding round.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
WuXi Biologics is pricing its shares at HK$20.60, the top end of its marketing range, valuing the IPO at $510 million, Bloomberg reports.
Outcome Health, a healthcare intelligence tech firm, has raised an outsize $500 million first round of funding, valuing it at $5.5 billion.
Medical device-focused CRO Genae has invested an undisclosed amount in Meditrix, a Japanese CRO in that same field, and obtained a call option to acquire the…
Chiltern has acquired Japanese CRO Integrated Development Associates (IDA), strengthening its presence in Asia.
Medrio, which focuses on electronic data capture, just got its first equity boost from an institutional investor—$30 million from Questa Capital Management.
PPD has expanded its vaccine sciences lab in Richmond, Virginia, by another 17,000 square feet and added vaccine efficacy testing capacity using cell-based…
LabCorp is planning a rejig of its CRO business Covance, and the short-term plan includes letting go of a lab along with the employees stationed there.
Outset Medical raised $76.5 million in its Series C round, which will go toward scaling up the commercial launch of its all-in-one dialysis device.